FDA official logo
GSRS logoPFDA official logo

TEZUSOMANT

UNII:P76WKQ7R9F
Type:INGREDIENT SUBSTANCE
Formula:C120H171N23O32S
Preferred Substance Name:TEZUSOMANT
InChIKey:
GSRS Full Record:

  • 2802416-72-2
  • 4-[[(1S,4S,10R,13S,19S,22S,25S,28S,47S,50S,53S,56S)-22-(4-aminobutyl)-10-[[(5S)-6-amino-5-[[(4S)-4-carboxy-4-[[(4S)-4-carboxy-4-(15-carboxypentadecanoylamino)butanoyl]amino]butanoyl]amino]-6-oxohexyl]carbamoyl]-56-(2-amino-2-oxoethyl)-4-[(4-carboxyphenyl)methyl]-19-[(5-hydroxy-1H-indol-3-yl)methyl]-53-(hydroxymethyl)-2,16,16-trimethyl-3,6,12,15,18,21,24,27,39,45,48,51,54,57-tetradecaoxo-13,47,50-tri(propan-2-yl)-8-thia-2,5,11,14,17,20,23,26,37,40,46,49,52,55,58-pentadecazatetracyclo[26.16.14.130,37.031,36]nonapentaconta-30(59),31,33,35-tetraen-25-yl]methyl]benzoic acid
  • L-Lysinamide, N-(15-carboxy-1-oxopentadecyl)-L-γ-glutamyl-L-γ-glutamyl-N6-[4-carboxy-N-(2-mercaptoacetyl)-L-phenylalanyl-N2-methyl-L-lysyl-L-valyl-L-valyl-L-seryl-L-asparaginyl-1-(carboxymethyl)-L-tryptophyl-4-carboxy-L-phenylalanyl-L-lysyl-5-hydroxy-L-tryptophyl-2-methylalanyl-L-valyl-L-cysteinyl]-, (7′→2′)-lactam, cyclic (1′→13′)-thioether
  • N-(15-carboxypentadecanoyl)-L-γ-glutamyl-L-γ-glutamyl-N<sup>6</sup>-{N<sup>6.2</sup>,C<sup>1.7</sup>-anhydro-S<sup>N.1</sup>,C<sup>3.13</sup>-cyclo[4-carboxy-N-(sulfanylacetyl)-L-phenylalanyl-N<sup>2</sup>-methyl-L-lysyl-L-valyl-L-valyl-L-seryl-L-asparaginyl-1-(carboxymethyl)-Ltryptophyl-4-carboxy-L-phenylalanyl-L-lysyl-5-hydroxy-L-tryptophyl-2-methylalanyl-L-valyl-L-alanyl]}-L-lysinamide
  • Tezusomant
  • tezusomant [INN]



UNII - P76WKQ7R9F | UNII Search Service